$MU — AVOID 📊 | 6 MONTHS THESIS

$MU — AVOID 📊 | 6 MONTHS THESIS 🎯 FQ3 FY2026 (ends May) | reported Jun 24 | Rev $23.9B | EPS $24.89 vs $20.98 🟢 | Margin 80.4% 💡 Consensus extrapolates strong memory pricing indefinitely, but memory cycles historically revert sharply; the market is mispricing cyclical risk at a 46x multiple when even sector peers average 18.7x and MU's own median is 3.9x. 🏢 Business Quality: 6 — Global leader in memory with scale advantages, but deeply cyclical, capital-intensive, and exposed to geopolitical and oversupply risks./10 📊 Valuation: Rich — Trailing P/E of 45.9x vs historical median 3.9x and sector median 18.7x; reverse DCF implies 6.8% FCF growth forever, which is aggressive for... 🔮 Catalyst: None — Q2 2026 earnings beat already occurred and guidance was not provided ⚖️ Avoid: Post-earnings beat, MU trades at a cyclically extreme multiple with no near-term catalyst; the 3-month risk/reward heavily favors the downside, and historical analogs suggest a major correction.

🎯 FQ3 FY2026 (ends May) | reported Jun 24 | Rev $23.9B | EPS $24.89 vs $20.98 🟢 | Margin 80.4%